Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03125811 · ClinicalTrials.gov registry record · Early Phase 1
Value of Ondansetron Medication vs Inhaled Isopropyl Therapy in the Emergency Department (VOMIITED)
A Early Phase 1 study, sponsored by Texas Tech University Health Sciences Center, El Paso.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 121
- Enrollment target
NCT03125811: Completed Early Phase 1 study, sponsored by Texas Tech University Health Sciences Center, El Paso.
NCT03125811 is a Early Phase 1 study that has completed, run by Texas Tech University Health Sciences Center, El Paso. The registered enrollment target is 121 participants, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (128% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03125811, a Early Phase 1 study, has completed, sponsored by Texas Tech University Health Sciences Center, El Paso.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 121 participants
- Enrollment target
Study Summary
This study will compare two different ways to relieve nausea and vomiting in the Emergency Department. The usual treatment for nausea/vomiting is a drug called Zofran, but new studies have suggested that smelling alcohol pads can also help to relieve nausea and vomiting.
Primary Outcome
Patient's nausea severity will be assessed at three time points by the study personnel using a verbal nausea rating scale over the course 60 minutes. Severity is scored 0-10 (0 = no nausea; 10 = severe nausea). Time points are at 0 minutes, 30 minutes, and 60 minutes.
Interventions
- OTHER Inhaled Isopropyl Alcohol (IPA)
- DRUG Oral Dissolvable Tablet Zofran (ondansetron)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 121 participants |
| Start Date | 2017-07-17 |
| Est. Completion | 2023-03-01 |
| Phase | Early Phase 1 |
What the finished NCT03125811 record still lists
NCT03125811 is an interventional study that assigns participants to a tested intervention. The registered 121 participants enrollment target is mid-sized for trials with a published cap, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (128% higher).
The record links to 0 conditions, and to 2 interventions - of which Inhaled Isopropyl Alcohol (IPA) is the first listed.
NCT03125811 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03125811 about?
NCT03125811 is a clinical study titled "Value of Ondansetron Medication vs Inhaled Isopropyl Therapy in the Emergency Department (VOMIITED)". This study will compare two different ways to relieve nausea and vomiting in the Emergency Department. The usual treatment for nausea/vomiting is a drug called Zofran, but new studies have suggested that smelling alcohol pads can also help to relieve nausea and vomiting.
What is the current status of trial NCT03125811?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 121 participants. The study started on 2017-07-17. Estimated completion is 2023-03-01.
What interventions are being tested in trial NCT03125811?
The interventions under investigation include: Inhaled Isopropyl Alcohol (IPA) (OTHER), Oral Dissolvable Tablet Zofran (ondansetron) (DRUG).
Who is sponsoring clinical trial NCT03125811?
This trial is sponsored by Texas Tech University Health Sciences Center, El Paso, which has 35 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03125811's enrollment target sits among peer trials
121 148th of 2000 higher than 1,853 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03476681 · 121 participants · Phase 1
Study of NEO-201 in Solid Tumors Expansion Cohorts
- NCT04655118 · 121 participants · Phase 2
Study of TL-895 in Subjects With Myelofibrosis or Indolent Systemic Mastocytosis
- NCT04676802 · 121 participants · Phase 2
Pain Relief After Trapeziectomy: Ibuprofen & Acetaminophen Versus Oxycodone
- NCT05169515 · 121 participants · Phase 1
A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Mosunetuzumab or Glofitamab in Combination With CC-220 and/or CC-99282 in Participants With B-Cell Non-Hodgkin Lymphoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI